US9181187, Compound G

ID: ALA3985387

Chembl Id: CHEMBL3985387

PubChem CID: 10144088

Max Phase: Preclinical

Molecular Formula: C25H25F3N2O5S2

Molecular Weight: 554.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1csc(S(=O)(=O)N(CC(C)C)c2ccc(C(F)(F)F)cc2OCc2ccc(/C=C/C(=O)O)cc2)n1

Standard InChI:  InChI=1S/C25H25F3N2O5S2/c1-16(2)13-30(37(33,34)24-29-17(3)15-36-24)21-10-9-20(25(26,27)28)12-22(21)35-14-19-6-4-18(5-7-19)8-11-23(31)32/h4-12,15-16H,13-14H2,1-3H3,(H,31,32)/b11-8+

Standard InChI Key:  SLHKHBZSGXVQFX-DHZHZOJOSA-N

Associated Targets(non-human)

Ptger1 Prostanoid EP1 receptor (301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 554.61Molecular Weight (Monoisotopic): 554.1157AlogP: 6.00#Rotatable Bonds: 10
Polar Surface Area: 96.80Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.82CX Basic pKa: CX LogP: 6.01CX LogD: 2.76
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.31Np Likeness Score: -1.16

References

1.  (2015)  Therapeutic agent for urinary excretion disorder, 

Source

Source(1):